Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Non-mandatory immunization and its potential impact on pertussis epidemiology.

Bergero PE, Fabricius G, Hozbor DF.

Arch Argent Pediatr. 2018 Dec 1;116(6):418-425. doi: 10.5546/aap.2018.eng.418. English, Spanish.

2.

Pertussis Maternal Immunization: Narrowing the Knowledge Gaps on the Duration of Transferred Protective Immunity and on Vaccination Frequency.

Gaillard ME, Bottero D, Zurita ME, Carriquiriborde F, Martin Aispuro P, Bartel E, Sabater-Martínez D, Bravo MS, Castuma C, Hozbor DF.

Front Immunol. 2017 Sep 6;8:1099. doi: 10.3389/fimmu.2017.01099. eCollection 2017.

3.

Potential Impact of Changes in the Schedule for Primary Diphtheria-Tetanus Toxoids-Pertussis Immunization as Control Strategy for Pertussis.

Bergero PE, Fabricius G, Hozbor DF, Theeten H, Hens N.

Pediatr Infect Dis J. 2018 Feb;37(2):e36-e42. doi: 10.1097/INF.0000000000001752.

PMID:
28859017
4.

Outer membrane vesicles: an attractive candidate for pertussis vaccines.

Hozbor DF.

Expert Rev Vaccines. 2017 Mar;16(3):193-196. doi: 10.1080/14760584.2017.1276832. Epub 2016 Dec 30. No abstract available.

PMID:
28010142
5.

Pertussis in Latin America: epidemiology and control strategies.

Falleiros Arlant LH, de Colsa A, Flores D, Brea J, Avila Aguero ML, Hozbor DF.

Expert Rev Anti Infect Ther. 2014 Oct;12(10):1265-75. doi: 10.1586/14787210.2014.948846. Epub 2014 Aug 19. Review.

PMID:
25139010
6.

Global population structure and evolution of Bordetella pertussis and their relationship with vaccination.

Bart MJ, Harris SR, Advani A, Arakawa Y, Bottero D, Bouchez V, Cassiday PK, Chiang CS, Dalby T, Fry NK, Gaillard ME, van Gent M, Guiso N, Hallander HO, Harvill ET, He Q, van der Heide HG, Heuvelman K, Hozbor DF, Kamachi K, Karataev GI, Lan R, Lutyńska A, Maharjan RP, Mertsola J, Miyamura T, Octavia S, Preston A, Quail MA, Sintchenko V, Stefanelli P, Tondella ML, Tsang RS, Xu Y, Yao SM, Zhang S, Parkhill J, Mooi FR.

MBio. 2014 Apr 22;5(2):e01074. doi: 10.1128/mBio.01074-14.

7.

Resurgence of pertussis calls for re-evaluation of pertussis animal models.

van der Ark AA, Hozbor DF, Boog CJ, Metz B, van den Dobbelsteen GP, van Els CA.

Expert Rev Vaccines. 2012 Sep;11(9):1121-37. doi: 10.1586/erv.12.83. Review.

PMID:
23151168
8.

Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina.

Fabricius G, Bergero PE, Ormazabal ME, Maltz AL, Hozbor DF.

Epidemiol Infect. 2013 Apr;141(4):718-34. doi: 10.1017/S0950268812001380. Epub 2012 Jul 6.

PMID:
22874088
9.

Bordetella holmesii in children suspected of pertussis in Argentina.

Bottero D, Griffith MM, Lara C, Flores D, Pianciola L, Gaillard ME, Mazzeo M, Zamboni MI, Spoleti MJ, Anchart E, Ruggeri D, Sorhouet C, Fiori S, Galas M, Tondella ML, Hozbor DF.

Epidemiol Infect. 2013 Apr;141(4):714-7. doi: 10.1017/S095026881200132X. Epub 2012 Jul 5.

PMID:
22874073
10.

Genotypic and phenotypic characterization of Bordetella pertussis strains used in different vaccine formulations in Latin America.

Bottero D, Gaillard ME, Basile LA, Fritz M, Hozbor DF.

J Appl Microbiol. 2012 Jun;112(6):1266-76. doi: 10.1111/j.1365-2672.2012.05299.x. Epub 2012 Apr 25.

11.

Mucosal innate response stimulation induced by lipopolysaccharide protects against Bordetella pertussis colonization.

Errea A, Moreno G, Sisti F, Fernández J, Rumbo M, Hozbor DF.

Med Microbiol Immunol. 2010 May;199(2):103-8. doi: 10.1007/s00430-010-0142-5. Epub 2010 Feb 9.

PMID:
20143087
12.

The symbiotic defect in a Sinorhizobium meliloti lipopolysaccharide mutant can be overcome by expression of other surface polysaccharides.

Hozbor DF, Pich Otero AJ, Lodeiro AR, Del Papa MF, Pistorio M, Lagares A.

Res Microbiol. 2004 Dec;155(10):855-60.

PMID:
15567281
13.
14.

Construction of a Sinorhizobium meliloti strain carrying a stable and non-transmissible chromosomal single copy of the green fluorescent protein GFP-P64L/S65T.

Pistorio M, Balagué LJ, Del Papa MF, Pich-Otero A, Lodeiro A, Hozbor DF, Lagares A.

FEMS Microbiol Lett. 2002 Sep 10;214(2):165-70.

15.

In vitro and in vivo characterization of a Bordetella bronchiseptica mutant strain with a deep rough lipopolysaccharide structure.

Sisti F, Fernández J, Rodríguez ME, Lagares A, Guiso N, Hozbor DF.

Infect Immun. 2002 Apr;70(4):1791-8.

16.

Fc receptor-mediated immunity against Bordetella pertussis.

Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, van de Winkel JG.

J Immunol. 2001 Dec 1;167(11):6545-51.

17.

Genetic characterization of a Sinorhizobium meliloti chromosomal region in lipopolysaccharide biosynthesis.

Lagares A, Hozbor DF, Niehaus K, Otero AJ, Lorenzen J, Arnold W, Pühler A.

J Bacteriol. 2001 Feb;183(4):1248-58.

18.

Recovery of Tn5-flanking bacterial DNA by vector-mediated walking from the transposon to the host genome.

Hozbor DF, Pich Otero AJ, Wynne ME, Petruccelli S, Lagares A.

Anal Biochem. 1998 Jun 1;259(2):286-8. No abstract available.

PMID:
9618212
19.

Rapid preparation of affinity-purified lipopolysaccharide samples for electrophoretic analysis.

Valverde C, Hozbor DF, Lagares A.

Biotechniques. 1997 Feb;22(2):230-2, 234, 236. No abstract available.

20.

Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.

Rodriguez ME, Hozbor DF, Yantorno OM.

J Ind Microbiol. 1996 Jul;17(1):53-5.

PMID:
8987690
21.

Effect of hydromechanical forces on the production of filamentous haemagglutinin and pertussis toxin of Bordetella pertussis.

Rodríguez ME, Samo AL, Hozbor DF, Yantorno OM.

J Ind Microbiol. 1993 Feb;12(2):103-8.

PMID:
7764157
22.

Effect of methyl-cyclodextrin on adenylate cyclase activity of Bordetella pertussis.

Hozbor DF, Samo A, Yantorno OM.

World J Microbiol Biotechnol. 1991 May;7(3):309-15. doi: 10.1007/BF00329396.

PMID:
24425017

Supplemental Content

Loading ...
Support Center